Melgrace
Natural health product licensed in Canada
- Licence holder
- Royal Natural Holdings Corp.
- NPN or DIN-HM
- 80017305
- Status
- Active licence
- Licence date
- 30 March 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
cellulose, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve symptoms associated with menopause. Used in Herbal Medicine to help relieve premenstrual symptoms. Traditionally used in Herbal Medicine to help relieve the pain associated with menstruation. Traditionally used in Herbal Medicine to help relieve muscle and joint pain associated with rheumatic conditions such as rheumatoid arthritis, osteoarthritis and/or fibrositis and of pain associated with neuralgia (such as sciatica). Traditionally used in Herbal Medicine to help ease nervous tension (calmative).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80017305
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.